Protein Kinase Inhibitors (Paperback). Este artículo no está disponible.
Idioma: inglés
Editorial: Elsevier Science & Technology, Oxford, 2022
- Tapa blanda
- Nuevo

Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Vendedor de 5 estrellas
Vendedor de IberLibro desde 22 de junio de 2007
No disponible
Tapa blanda
Condición: Nuevo
EUR 340,87
Descripción del artículo del vendedor
Paperback. Protein Kinase Inhibitors: From Discovery to Therapeutics Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
N° de ref. del artículo 9780323912877
- Título
- Protein Kinase Inhibitors (Paperback)
- Autor
- Md. Imtaiyaz Hassan
- Editorial
- Elsevier Science & Technology, Oxford
- Año de publicación
- 2022
- Estado
- new
- Encuadernación
- Paperback
- Idioma
- inglés
- ISBN 10
- 0323912877
- ISBN 13
- 9780323912877
Protein Kinase Inhibitors: From Discovery to Therapeutics offers a foundational, pragmatic overview of protein kinases inhibitors and their potential role in disease modulation and treatment. Here, international experts in the field offer an integrated discussion of kinase inhibitor biology, biomarker discovery, and methods for drug design and development. After a brief overview of kinases and kinase inhibitors, subsequent chapters discuss individual kinases that are representative of the wider kinases and kinase families, including their roles in disease pathogenesis, underlying mechanisms, potential inhibitors and their modes of action for therapeutic modulation. Several potential drugs under different stages of clinical trials are discussed, including their relevance to cancer, diabetes, obesity, cardiovascular, neurological, and auto-immune and inflammatory disease, among other disorders. The book also addresses the challenges and opportunities for future kinase inhibitor development.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Dr. Md. Imtaiyaz Hassan, Ph.D., FRSB., FRSC., is a Professor at the Centre for Interdisciplinary Research in Basic Sciences, in Jamia Millia Islamia, New Delhi, India. His research focuses on and design and development of potent and selective kinase inhibitors, as well as understanding the mechanism of folding and dynamic behavior of potential drug targets. Dr. Hassan has published widely in such peer reviewed journals as the International Journal of Biological Macromolecules, Spectrochimica Acta, Scientific Reports, and the OMICS A Journal of Integrative Biology.
Dr. Saba Noor is a Research Associate at the Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India. Dr. Noor has expertise in molecular oncology, and her current research interests lie in development of kinase inhibitors for use in cancer therapeutics. She has published in such peer reviewed journals as Frontiers in Microbiology and International Journal of Biological Macromolecules, among other journals.
Dr. Saba Noor is a Research Associate at the Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India. Dr. Noor has expertise in molecular oncology, and her current research interests lie in development of kinase inhibitors for use in cancer therapeutics. She has published in such peer reviewed journals as Frontiers in Microbiology and International Journal of Biological Macromolecules, among other journals.
“Acerca de” puede pertenecer a otra edición de este título.